Comparison of two dosages of Ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb: A randomised, double-blind, multicentric clinical trial

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 11, 1999, Pages 900-904

  Schweizer, Johannes ^a,c   Hautmann, Christian ^b  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^b GKM Gesellschaft Therapieforsch mbH   (Germany)

^c KLINIKUM CHEMNITZ   (Germany)

Author keywords

Clinical trial; EGb 761; Ginkgo biloba extract; Peripheral arterial occlusive disease; Rokan

Indexed keywords

GINKGO BILOBA EXTRACT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

GINKGO BILOBA;

EID: 0032735682     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300524     Document Type: Article

References (20)

1. Böhmer, D., Kalinski, S., Michaelis, P. et al., Behandlung der pAVK mit Ginkgo-biloba-Extrakt (GBE) oder pentoxyfillin. Eine studie zur beurteilung von wirk-samkeit und verträglichkeit. Herz/-Kreislauf 20, 5 (1988)
2. Bauer, U., in: Advances in Ginkgo biloba extract research, vol. 3. Cardiovascular Effects of Ginkgo biloba Extract (EGb 761), F. Clostre, F. V. DeFeudis, (eds.), pp. 121-133, Elsevier, Paris (1994)
3. Bauer, U., 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneim.-Forsch./Drug Res. 34 (I), 716 (1984)
4. Berndt, E. D., Kramar, M., Medikamentöse therapie der peripheren arteriellen verschluβkrankheit im stadium IIb. Eine bizentrische vergleichsstudie zwischen Ginkgo-biloba-Extrakt und buflomedilhydrochlorid. Therapiewoche 37, 2815 (1987)
5. Blume, J., Kieser, M., Hölscher, U., Placebokontrol-lierte doppelblindstudie zur wirksamkeit von Ginkgo-biloba-Spezialextrakt EGb 761 bei austrainierten patienten mit claudicatio intermittens. VASA 25, 265(1996)
6. Bulling, B., in: Advances in Ginkgo biloba extract research, vol. 3. Cardiovascular Effects of Ginkgo Biloba Extract (EGb 761), F Clostre, F V. DeFeudis (eds.), pp. 143-150, Elsevier, Paris (1994)
7. 2 determination. Angiology 45, 413 (1994)
8. Peters, H., Kieser, M., Hölscher, U., Demonstration of the efficacy of Ginkgo biloba special extract EGb 761 on intermittent claudication - A placebo-controlled double-blind multicenter trial. VASA 27, 106 (1998)
9. Salz, H., Zur wirksamkeit eines Ginkgo biloba-Präparates bet arteriellen durchblutungsstörungen der unteren extremitäten. Kontrollierte doppelblind-cross-over-studie. Therapie der Gegenwart 119, 1345 (1980)
10. Thomson, G. J. L., Vohra, R. K ., Carr, M. H. et al., A clinical trial of Ginkgo biloba extract in patients with intermittent claudication. Int. Angiol. 9, 75 (1990)
11. Li, A. L., Landsmann, B., Schanowsky-Bouvier, P. et al., Hemorheology and walking of peripheral arterial occlusive disease patients during treatment with Ginkgo Biloba extract. Chang Kuo Yao L. Hsueh Pao 19, 417 (1998)
12. Heidrich, II., Allenberg, J., Cachovan, M. et al., Prüfrichtlinien für therapiestudien im fontaine-stadium I1 IV bei peripherer arterieller verschluβkrankheit. VASA 21,333 (1992)
13. Artmann, G., Schikarski, C., Shi, Y. D., A comparative study of antioxidative capacity of phytopharmaka.Clin. Hemorrheol. 13, 117 (1992)
14. Artmann, G., Schikarski, C., Ginkgo biloba extract (EGb 761) protects red blood cells from oxidative damage. Clin. Hemorrheol. 13, 529 (1993)
15. Gardès-Albert, M., Ferradini, C., Sekaki, A. et al., in: Advances in Ginkgo biloba extract research, vol. 2. Ginkgo biloba Extract (EGb 761) as a Free-radical Scavenger, C. Ferradini, M. T. Droy-Lefaix, Y. Christen (eds.), pp. 1-11 Elsevier, Paris (1993)
16. Pincemail, J., Deby, C., Propriétés antiradicalaires de I'extrait de Ginkgo biloba. Presse Méd. 15, 1475 (1986)
17. Rapin, J. R., Provost, P., DeFeudis, F. V. et al., Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) and bilobalide on glucose uptake and glycogen synthesis in rat erythrocytes: An ex vivo study. Drug Dev. Res. 31, 164 (1994)
18. Sellak, H., Marquetty, C., Pasquier, C., in: Advances in Ginkgo biloba Extract research, vol. 3. Cardiovascular Effects of Ginkgo biloba Extract (EGb 761), F. Clostre, F V. DeFeudis (eds.), pp. 69-78, Elsevier, Paris(1994)
19. Stücker, O., Pons, C., Duverger, J. P. et al., in: Advances in Ginkgo biloba extract research, vol. 3. Cardiovascular Effects of Ginkgo biloba Extract (EGb 761), F. Clostre, F. V. DeFeudis (eds.), pp. 27-30, Elsevier, Paris (1994)
20. Stücker, O., Pons, C., Duverger, J. P. et al., in Advances in Ginkgo biloba Extract research, vol. 3. Cardiovascular Effects of Ginkgo biloba Extract (EGb 761), F. Clostre, F. V. DeFeudis (eds.), pp. 31-37, Elsevier, Paris (1994)